Tauriga Sciences, Inc.
TAUG · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Revenue | $285 | $234 | $57 | $1 |
| % Growth | 21.7% | 310.2% | 4,709.3% | – |
| Cost of Goods Sold | $163 | $197 | $37 | $1 |
| Gross Profit | $123 | $37 | $20 | $0 |
| % Margin | 43% | 15.9% | 35% | 39.8% |
| R&D Expenses | $273 | $7 | $14 | $10 |
| G&A Expenses | $2,964 | $1,880 | $1,084 | $1,944 |
| SG&A Expenses | $3,237 | $2,068 | $1,088 | $1,961 |
| Sales & Mktg Exp. | $273 | $188 | $4 | $17 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,512 | $2,076 | $1,102 | $1,972 |
| Operating Income | -$3,389 | -$2,039 | -$1,083 | -$1,895 |
| % Margin | -1,188% | -869.9% | -1,895.7% | -159,542.1% |
| Other Income/Exp. Net | -$237 | -$994 | -$12 | $1,898 |
| Pre-Tax Income | -$3,626 | -$3,033 | -$1,095 | $3 |
| Tax Expense | $1,093 | $902 | $2 | $39 |
| Net Income | -$3,626 | -$3,033 | -$1,097 | -$36 |
| % Margin | -1,271% | -1,294.1% | -1,920.8% | -3,041% |
| EPS | -0.024 | -0.049 | -0.02 | -0.001 |
| % Growth | 49.8% | -146.7% | -1,690.9% | – |
| EPS Diluted | -0.024 | -0.049 | -0.02 | -0.001 |
| Weighted Avg Shares Out | 193,622 | 80,950 | 55,767 | 33,079 |
| Weighted Avg Shares Out Dil | 193,622 | 80,950 | 55,767 | 55,809 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $1,093 | $902 | $281 | $292 |
| Depreciation & Amortization | $2 | $1 | $1 | $1 |
| EBITDA | -$2,532 | -$2,130 | -$816 | -$1,972 |
| % Margin | -887.3% | -908.8% | -1,429% | -165,982.7% |